References
Wagner K, Phillip T, Heinemeyer HH, et al. Interaction of cyclosporin and calcium antagonists. Transplant Proc 1989; 21: 1453–6
Sahloul MZ, al-Kiek R, Ivanovich P, et al. Nonsteroidal anti-inflammatory drugs and antihypertensives. Nephron 1990; 56: 345–52
Johnson AG, Nguyen TV, Day RO. Do nonsteroidal anti-inflammatory drugs affect blood pressure? A meta-analysis. Ann Intern Med 1994; 112: 289–300
Honig PK, Woolsley RL, Zamani K, et al. Changes in the pharmacokinetics and electrocardiographic pharmacodynamics of terfenadine with concomitant administration of erythromycin. Clin Pharmacol Ther 1992; 52: 231–8
Creutzfeldt W. Risk-benefit assessment of omeprazole in the treatment of gastrointestinal disorders. Drug Saf 1994; 10: 66–82
Houston JB. Utility of in vitro drug metabolism data in predicting in vivo metabolic clearance. Biochem Pharmacol 1994; 47: 1469–79
Sternbach H. The serotonin syndrome. Am J Psychiatry 1991; 148: 705–13
Dursun SM, Mathew VM, Reveley MA. Toxic serotonin syndrome after fluoxetine and carbamezepine [letter]. Lancet 1993; 342: 442
Muly EC, McDonald W, Steffens D, et al. Serotonin syndrome produced by a combination of fluoxetine and lithium. Am J Psychiatry 1993; 150: 1565
Price LH, Heninger MD. Lithium in the treatment of mood disorders. N Engl J Med 1994; 331: 591–8
Livingston MG. Interactions with selective MAOIs. Lancet 1995; 345: 533–4
Neuvonen PJ, Pohjola-Sintonen S, Tacke U, et al. Five fatal cases of serotonin syndrome after moclobemide-citalopram and moclobemide-clomipramine overdoses. Lancet 1993; 342: 1419
Lefebvre H, Noblet C, Moore N, et al. Pseudophaeochromocytoma after multiple drug interactions involving the selective monoamine oxidase inhibitor selegiline. Clin Endocrinol 1995; 42: 92–9
Further Reading
Hansten PD, Horn JR. Drug interactions and updates, 8th ed. Vancouver: Applied Therapeutics, 1993
Jankel CA, Fitterman LK. Epidemiology of drug-drug interactions as a cause of hospital admissions. Drug Saf 1993; 9: 51–9
Mclnnes GT, Brodie MJ. Drug interactions that matter: a critical appraisal. Drugs 1988; 36: 83–110
Reactions® Weekly and CD-ROM Database. Auckland: Adis International
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Quinn, D.I., Day, R.O. Drug Interactions of Clinical Importance. Drug-Safety 12, 393–452 (1995). https://doi.org/10.2165/00002018-199512060-00005
Published:
Issue Date:
DOI: https://doi.org/10.2165/00002018-199512060-00005